Picture of Beigene logo

6160 Beigene Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Annual cashflow statement for Beigene, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSARSARSARSARS
Standards:
CAS
CAS
CAS
CAS
CAS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital-237-7,254-9,674-12,843-14,880
Other Operating Cash Flow
Cash from Operating Activities-5,180-8,285-7,800-7,793-1,259
Capital Expenditures-992-2,256-2,335-4,106-3,418
Purchase of Fixed Assets
Other Investing Cash Flow Items-20,8645,3894,7494,2231,030
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-21,8563,1332,415117-2,389
Financing Cash Flow Items29,41522,401146172-167
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities31,37022,867-4482,558826
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4,24417,674-5,764-5,073-2,841